Alvotech Humira Settlement Sets Up Interchangeable Adalimumab Showdown

US Launch Date Matches That Of BI’s Cyltezo Interchangeable Humira Biosimilar

Knights Chess Pieces Black White Face Off
Alvotech and Boehringer Ingelheim could launch rival interchangeable Humira biosimilars on the same date • Source: Thomas LENNE / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products